FDA has approved another ustekinumab biosimilar (Wezlana) as being interchangeable for use in adults with plaque psorias
Tweet Content
FDA has approved another ustekinumab biosimilar (Wezlana) as being interchangeable for use in adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. https://t.co/zbQKjmKgZh https://t.co/UuTDRgCBIV
Links
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases
https://bit.ly/3tZFdo4
Show on Archive Page
On
Display in Search Results
On
PDQ
Off